Swixx Biopharma OÜ
Swixx Biopharma OÜ is a OÜ based in Tallinn, registry code 12741121, status: active. Main activity: Other business support service activities n.e.c.. According to EMTA, turnover for Q3 2026 was €1 060 288 with 27 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1.1 mn €above 98% of companiesindustry median 14 685 € · companies in the industry: 1 227
- Labour taxes per employee 10 482 €above 98% of companiesindustry median 1 350 € · companies in the industry: 777
- Revenue · 2025 4.4 mn €above 98% of companiesindustry median 3 483 € · companies in the industry: 3 688
- Net profit margin · 2025 7.8 %above 45% of companiesindustry median 11.2 % · companies in the industry: 2 113
Taxes and turnover
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 060 288 | 283 643 | 283 010 | 27 |
| Q2 2026 | 1 286 808 | 413 093 | 425 116 | 27 |
| Q1 2026 | 1 225 898 | 261 274 | 268 853 | 27 |
| Q4 2025 | 1 307 026 | 284 901 | 283 650 | 26 |
| Q3 2025 | 1 063 445 | 256 268 | 258 986 | 26 |
| Q2 2025 | 1 040 940 | 250 931 | 244 865 | 25 |
| Q1 2025 | 983 739 | 354 731 | 379 593 | 24 |
| Q4 2024 | 1 048 033 | 223 198 | 230 369 | 25 |
| Q3 2024 | 1 000 727 | 224 127 | 231 966 | 24 |
| Q2 2024 | 1 120 457 | 200 585 | 195 307 | 24 |
| Q1 2024 | 936 353 | 275 613 | 281 286 | 24 |
| Q4 2023 | 936 100 | 194 331 | 193 387 | 23 |
| Q3 2023 | 845 773 | 183 757 | 183 714 | 23 |
| Q2 2023 | 914 534 | 252 817 | 254 335 | 22 |
| Q1 2023 | 814 318 | 174 388 | 176 609 | 23 |
| Q4 2022 | 878 807 | 184 870 | 177 744 | 23 |
| Q3 2022 | 748 826 | 157 738 | 160 860 | 24 |
| Q2 2022 | 745 699 | 147 551 | 152 097 | 21 |
| Q1 2022 | 541 136 | 137 766 | 145 289 | 22 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 4 406 198 | 345 740 | 2 672 031 | 1 642 627 | 1 033 638 | 27 |
| 2024 | 4 001 491 | 206 603 | 2 380 315 | 1 206 320 | 687 898 | 25 |
| 2023 | — | — | — | — | — | 23 |
| 2022 | 2 988 612 | 156 940 | 1 726 606 | 678 627 | 305 356 | 20 |
| 2021 | 821 591 | 40 650 | 529 574 | 297 246 | 148 415 | 6 |
| 2020 | 651 565 | 33 257 | 386 274 | 227 613 | 107 765 | 4 |
| 2019 | 633 981 | 23 410 | 327 431 | 176 864 | 74 508 | 3 |
| 2018 | — | — | — | — | — | 2 |
| 2017 | — | — | — | — | — | 2 |
| 2016 | — | — | — | — | — | 2 |
| 2015 | — | — | — | — | — | 1 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 16 Jun 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 27 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 3 Jul 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 2 Jun 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 9 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 1 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 11 Jun 2020 | Company’s own | e-Äriregister |
Board
- Rima JankovskaBoard member · since 7 Apr 2022
- Dezső Dr. MárthaBoard member · since 22 Sep 2023
- Laur SaarBoard member · since 22 Sep 2023
- Piret TuulBoard member · since 2 Jul 2024
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Swixx Biopharma AGLegal person · 2 500 €
Beneficial owners
- Barry Bahram SiadatControl by other means (contractual, family or other ties) · USA · since 23 Jul 2026
- Jamshid Mark KeynejadControl by other means (contractual, family or other ties) · USA · since 23 Jul 2026
Founders and other persons
- A-Firmad OÜFounder · 2 500 € · 23 Oct 2014
- Grant Thornton Baltic OÜAudit firm · 31 Mar 2025
Related companies
Activities (EMTAK)
- 82991Other business support service activities n.e.c. Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10201515 / 17 2 Jul 2024 |
Amendment entry | In force 2 Jul 2024 |
||
| Ä 10201515 / M1 1 Jul 2024 |
Procedural ruling | 15 Jul 2024 | Deficiencies eliminated 3 Jul 2024 |
|
| Ä 10201515 / 16 22 Sep 2023 |
Amendment entry | In force 22 Sep 2023 |
||
| Ä 10201515 / 15 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 10201515 / 14 12 Aug 2022 |
Amendment under Commercial Code § 525 (2) | In force 12 Aug 2022 |
||
| Ä 10201515 / 13 9 Jun 2022 |
Amendment entry | In force 9 Jun 2022 |
||
| Ä 10201515 / 12 7 Apr 2022 |
Amendment entry | In force 7 Apr 2022 |
||
| Ä 10201515 / 11 6 Jan 2022 |
Amendment under Commercial Code § 525 (2) | In force 6 Jan 2022 |
||
| Ä 10201515 / 10 21 Sep 2021 |
Amendment entry | In force 21 Sep 2021 |
||
| Ä 10201515 / 9 11 Jun 2020 |
Amendment entry | In force 11 Jun 2020 |
||
| Ä 10201515 / 8 6 Jun 2019 |
Amendment entry | In force 6 Jun 2019 |
||
| Ä 10201515 / 7 23 May 2018 |
Amendment entry | In force 23 May 2018 |
||
| Ä 10201515 / 6 19 Jan 2018 |
Amendment entry | In force 19 Jan 2018 |
||
| Ä 10201515 / 5 13 Feb 2017 |
Amendment under Commercial Code § 525 (2) | In force 13 Feb 2017 |
||
| Ä 10201515 / 4 13 Jan 2016 |
Amendment entry | In force 13 Jan 2016 |
||
| Ä 10201515 / 3 3 Jun 2015 |
Amendment entry | In force 3 Jun 2015 |
||
| Ä 10201515 / 2 28 Nov 2014 |
Amendment entry | In force 28 Nov 2014 |
||
| Ä 10201515 23 Oct 2014 |
First entry | In force 23 Oct 2014 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data